More Syntara Limited news Syntara LimitedASX: SNT PXS Cancer Drug Ready to Commence Phase 2 Studies Q4 2020 Apr 28, 2020 at 2:45 AM UTC · Issued by Syntara Limited As issuedPlain English Syntara Limited has released a press release. View Attachment
